Lupin share news, announcements and annual reports
NSE: LUPINBSE: 500257Pharmaceuticals & BiotechnologyMid Cap
Lupin Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1993 on BSE, Sep 2001 on NSE
Last close ₹2,011.00up ₹21.10 (1.06%)BSE ₹2,009.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,989.90.
30 Oct: open ₹1,995.70, high ₹2,021.80, low ₹1,974.00
52-week range of traded prices to 30 Oct 2026
₹1,892.90Low, 23 Oct 2026₹2,529.50High, 16 Jul 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹91,961 Cr105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 16.63
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 15.11
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.10
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.90%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 30.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.26
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,59,66358.6% delivered
Lupin shareholding disclosures
320 filed, newest first. Page 5 of 7.
Oct 2015
Aug 2015
Apr 2015
Feb 2015
Jan 2015
Dec 2014
Nov 2014
19 Nov · Disclosure
Allotment Committee of Directors at its meeting held on November 19, 2014 has allotted 66162 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 89,82,15,552 consisting 44,91,07,776 equity shares of Rs. 2/- each.12 Nov · Disclosure
Pursuant to Clause 25 of the Listing Agreement, Company has granted 32900 options to the employees of its Subsidiary Companies, under Lupin Subsidiary Companies Employees Stock Option Plan 2011 on November 11, 2014, at the exercise price of Rs.1430.95. Company further stated that one equity share of Rs.2/- each is covered by each option. The options issued are exercisable at the 'market price' as defined in the SEBI (SBEB) Regulations, 2014 , in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.
Oct 2014
9 Oct · Disclosure
On October 8, 2014, the Company has granted 4500 options to their employees under Lupin Employees Stock Option Plan 2011, at the exercise price of Rs. 1368.05. Company has informed that that one equity share of 2/- each is covered by each option. The options issued are exercisable at the market price as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.
Sep 2014
Aug 2014
Jul 2014
Jun 2014
May 2014
Apr 2014
Mar 2014
Feb 2014
Jan 2014
Dec 2013
30 Dec · Disclosure
Company has granted 16700 options to the employee of its subsidiary Company, under Lupin Subsidiary Companies Employees Stock Option Plan 2011 on December 27, 2013, at the exercise price of Rs.907/-. Please note that one equity share of Rs.2/- each is covered by each option. The options issued are exercisable at the market price as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.
Nov 2013
Oct 2013
9 Oct · Disclosure
Company has granted 50,000 options under Lupin Employees Stock Option Plan 2003 , at the exercise price of Rs.439.43 on October 7, 2013. One equity share of Rs.2/- each is covered by each option. The options issued are exercisable after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.
Aug 2013
7 Aug · Disclosure
Company has granted 98590 options to the employees of its subsidiary companies, under "Lupin Subsidiary Companies Employees Stock Option Plan 2011" at the exercise price of Rs 873.85 on August 02, 2013. Further, one equity share of Rs.2/- each is covered by each option. The options issued are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.
Jul 2013
27 Jul · Disclosure
On July 26, 2013 the Company has granted 945000 options to its employees under "Lupin Employees Stock Option Plan 2011" at an exercise price of Rs. 864.75.Further the Company has informed that, one equity share of Rs. 2/- each is covered by each option. The options granted are exercisable at the 'market price' as defined in the SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant.
May 2013
Apr 2013
Mar 2013